Metformin may help to prevent primary liver cancer
Metformin, a drug widely used to treat Type II diabetes, may help to prevent primary liver cancer
Metformin, a drug widely used to treat Type II diabetes, may help to prevent primary liver cancer
by Bruce Sylvester – Normal weight persons with weight concentrated in their belly run a higher death risk of CVD-related death than obese-only individuals, researchers reported at ESC.
by Zara Qadir – BMI still offers a simple numeric measure of a person’s “thickness” or “thinness”. However, normal weight individuals who carry weight concentrated in their belly… read more.
by Bruce Sylvester – Obese persons who are metabolically healthy and fit have no more risk of developing or dying from cardiovascular disease or cancer than persons of… read more.
by Bruce Sylvester – The combination of obesity and low vitamin D deficiency appears to cause a greater risk of insulin resistance than either factor alone, researchers reported… read more.
by Gary Finnegan – World Health Matters (China) – Child diabetes levels in China are higher than those in the US, according to a startling new study based… read more.
by Bruce Sylvester – Two studies presented at EASL suggest the real human and economic costs of liver disease across Europe.
by Bruce Sylvester – Combination metformin and rosiglitazone is more effective than metformin monotherapy in youth with recent-onset type 2 diabetes,
The majority of patients with chronic obstructive pulmonary disease (COPD) referred for pulmonary rehabilitation have multiple extra-pulmonary comorbidities, according to a new study from the Netherlands.
by Dr Sunil Upadhyay – Breast cancer is one of the most common malignancies in women all over the world and its complex and multi-factorial aetiology remains unclear…. read more.
New guidelines on dyslipidemia and the prevention of atherogenesis give official sanction to something endocrinologists have been doing for years: lowering LDL targets.